Hydroxyurea in Sickle Cell Disease
- 1 February 1996
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 334 (5) , 333-334
- https://doi.org/10.1056/nejm199602013340516
Abstract
We wish to comment further on the possible risks of hydroxyurea therapy in sickle cell disease, a subject of considerable attention since the results of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia were reported by Charache et al. (May 18 issue).1Keywords
This publication has 1 reference indexed in Scilit: